Recent Episodes
-
The importance of balancing AI and people in drug development
May 27, 2025 – 21:11 -
Two CEOs discuss bracing for tariffs, NIH grant cuts and gifting China biopharma leadership position
Apr 23, 2025 – 31:13 -
As biopharma investments stumble, med tech surges
Mar 30, 2025 – 12:26 -
Mega money well spent? Mammoth mergers fall short of the dream
Feb 24, 2025 – 19:13 -
Healing the health divide for women
Nov 22, 2024 – 20:54 -
Modifi gets creative on the rocky road to a multibillion-dollar buyout
Nov 13, 2024 – 23:56 -
A quantum leap into the future of drug development
Oct 17, 2024 – 17:32 -
Gene and cell therapies will propel innovation, says Astellas CCO
Oct 7, 2024 – 27:17 -
Capricor’s CEO pursues a BLA and talks rare disease
Sep 27, 2024 – 15:50 -
The first half of 2024 was strong as M&As and financings dominate
Jul 26, 2024 – 18:01 -
The cost of delays in development and sales: It’s probably not what you think
Jul 17, 2024 – 16:44 -
ASCO preview: ADCs and radiotherapies at the forefront of this year’s conference
May 30, 2024 – 13:11 -
Fibrobiologics walks the unconventional financing path
May 15, 2024 – 18:16 -
Back to fundamentals: The latest numbers point to better times
May 6, 2024 – 21:38 -
Mark McKenna storms back with Mirador and eyes the development landscape
Apr 23, 2024 – 25:01 -
Biopharma execs seek to avoid pain points in AI integration
Apr 16, 2024 – 19:19 -
Six biopharma executives consider a tough 2023 and are hopeful for a better 2024
Dec 11, 2023 – 17:05 -
AI: driving drug development from effective to remarkable
Sep 6, 2023 – 26:32 -
The struggle is real: The first half of 2023 was an uphill climb
Aug 16, 2023 – 25:47 -
The biosimilars challenge to Humira revs up
Jul 20, 2023 – 17:06 -
Preventing opioid overdoses with a smart patch
Jun 5, 2023 – 23:20 -
Better times ahead for the biopharma sector? Could be, the new numbers say
Apr 24, 2023 – 28:02 -
Radiopharmaceuticals: The next big disrupter?
Apr 5, 2023 – 13:58 -
Cambrian carves out a new niche as it works to keep people from getting sick
Feb 21, 2023 – 28:06 -
Rethinking obesity: Fitness may be more directly linked to health than weight
Jan 30, 2023 – 21:23 -
Looking ahead to 2023: CEOs contemplate the new normal
Dec 5, 2022 – 24:55 -
Psychedelic evolution: Mindset Pharma looks to change mental health treatment
Sep 21, 2022 – 25:48 -
$1B+ biopharma deals keep values afloat, even amid muted volume
Sep 8, 2022 – 28:20 -
Extending the human lifespan
Jul 18, 2022 – 41:42 -
New therapies vie to change the fatal course of amyotrophic lateral sclerosis
Jun 3, 2022 – 33:08 -
Biopharma’s correction? 2022 1Q investments are both up and down
May 2, 2022 – 17:41 -
Who advises the CDC on big COVID decisions?
Feb 23, 2022 – 24:27 -
Long COVID: Potentially the next public health crisis
Feb 14, 2022 – 23:46 -
What happens when your inventor is an artificial intelligence?
Dec 14, 2021 – 29:14 -
Another record year for biopharma financings bodes well for 2022
Dec 9, 2021 – 18:41 -
Aduhelm’s hard lessons and what it means for other Alzheimer’s drugs
Dec 9, 2021 – 32:30 -
Supply Chain Geeky: Managing through the challenges of COVID-19 with an eye to what’s at stake
Dec 9, 2021 – 24:00 -
Regulatory Gemish: COVID-19’s big impacts on the FDA and beyond
Dec 9, 2021 – 28:54 -
Reality check: How did industry develop COVID-19 vaccines and drugs so fast?
Oct 26, 2021 – 16:39 -
Merck’s new COVID-19 pill will save lives, but at what price?
Oct 18, 2021 – 28:16 -
Newly approved cervical cancer drug Tivdak gives patients a new option
Sep 24, 2021 – 18:01 -
DNA vaccines: a better path to taming the pandemic?
Sep 17, 2021 – 26:08 -
Rising to the COVID-19 challenge, clinical trials evolve
Sep 2, 2021 – 24:50 -
A ‘Revolution’ in drugging the undruggable hits a speed bump but motors on
Aug 20, 2021 – 31:28 -
As dementia cases grow, biomarkers and new therapies key to unlocking treatment
Jul 30, 2021 – 34:05 -
As biopharma deals keep pace, M&A volumes languish
Jul 9, 2021 – 14:22 -
Iteos brings Glaxosmithkline a third checkpoint-targeting antibody in a $2B deal
Jun 16, 2021 – 12:33 -
Finally, a new medicine for Alzheimer’s disease
Jun 10, 2021 – 09:17 -
The BioWorld Insider Podcast - trailer
Jun 4, 2021 – 00:35
Recent Reviews
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.